Intravascular hemolysis leading to death has been reported in Rh0(D)-positive patients treated for immune thrombocytopenic purpura (ITP) with Rh0(D) Immune Globulin Intravenous (Human) products. Intravascular hemolysis can lead to clinically compromising anemia and multi-system organ failure including ...
It is usually possible to prevent sensitization from occurring following the first exposure by administering a single dose of anti-Rh antibodies in the form of Rh0(D) immune globulin (RhoGAM) immediately following exposure to the D antigen. View chapterExplore book Bleeding, Hemostasis, and ...
You are encouraged to report negative side effects of prescription drugs to the FDA. Visitwww.fda.gov/medwatchor call 1-800-FDA-1088. References HyperRHO S/D Full Dose (Rho[D] immune globulin [human]) Prescribing Information. Grifols. ...